MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$199,372K
Cash and cash
equivalents
$184,869K
Accounts receivable, net
$182,183K
Inventories, net
$87,062K
Prepaid expenses and
other current assets
$78,094K
Total current assets
$731,580K
Intangible assets, net
$549,712K
Goodwill
$120,668K
Other assets
$56,453K
Deferred income tax
assets, net
$30,820K
Property and equipment,
net
$10,042K
Restricted cash
$1,450K
Total assets
$1,500,725K
Total liabilities and
stockholders' equity
$1,500,725K
Total stockholders'
equity
$1,076,805K
Total liabilities
$423,920K
Accumulated other
comprehensive loss, net of tax
-$255K
Additional paid-in capital
$561,419K
Retained earnings
$515,583K
Total current
liabilities
$373,929K
Operating lease
liabilities, long-term
$30,267K
Other liabilities
$19,518K
Contingent consideration,
long-term
$206K
Common stock, 0.001 par
value 130,000,000...
$58K
Accrued product returns
and rebates
$189,720K
Accounts payable and
accrued liabilities
$101,244K
Other current
liabilities
$82,965K
Back
Back
Balance Sheet
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
source: myfinsight.com